| 000 | 01792 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517110252.0 | ||
| 264 | 0 | _c20170328 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1472-8206 | ||
| 024 | 7 |
_a10.1111/fcp.12225 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Wei | |
| 245 | 0 | 0 |
_aDihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway. _h[electronic resource] |
| 260 |
_bFundamental & clinical pharmacology _cDec 2016 |
||
| 300 |
_a596-606 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xmetabolism |
| 650 | 0 | 4 |
_aBone Morphogenetic Proteins _xmetabolism |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aFlavonoids _xphysiology |
| 650 | 0 | 4 |
_aFlavonols _xpharmacology |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMesenchymal Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aOsteoblasts _xdrug effects |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
| 650 | 0 | 4 |
_abeta Catenin _xmetabolism |
| 700 | 1 | _aWang, Shengdong | |
| 700 | 1 | _aYin, Houfa | |
| 700 | 1 | _aChen, Erman | |
| 700 | 1 | _aXue, Deting | |
| 700 | 1 | _aZheng, Qiang | |
| 700 | 1 | _aGao, Xiang | |
| 700 | 1 | _aPan, Zhijun | |
| 773 | 0 |
_tFundamental & clinical pharmacology _gvol. 30 _gno. 6 _gp. 596-606 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/fcp.12225 _zAvailable from publisher's website |
| 999 |
_c26276688 _d26276688 |
||